GlaxoSmithKline's consumer health business will be named Haleon following its planned spinoff and listing on the London Stock Exchange later this year, according to the drugmaker. The name of the ...

McNamara has been with GSK since 2015, when he joined the company as head of consumer health for Europe and the Americas, and previously worked for 10 years at Novartis, ultimately heading up its ...

With the launch of Polident, which is the global market leader in the denture care, the company has reinforced its presence in the overall oral health category in India, GSK Consumer Healthcare ...

Painkiller brands Panadol and Anadin will be bought under one roof under a giant deal between drug firms GlaxoSmithKline and Pfizer. The firms are combining their consumer healthcare businesses ...

During the Republican primary campaign, Excedrin's social media team began to notice consumers tweeting about the crowded debates, stating that comments from politicians were giving them a headache.

To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...

To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...

Editorial Note: Blueprint may earn a commission from affiliate partner links featured here on our site. This commission does not influence our editors' opinions or evaluations. Please view our ...

The deal, which is valued at ₹317 billion, will see HUL take over GSK’s consumer healthcare operations and merge them with itself. In exchange, GSK will get a 5.7% stake in HUL, which is ...

GlaxoSmithKline will combine its consumer health business with Pfizer - split at 68% to 32% in equity holdings respectively - and its shares rose as much as 7.4% on the announcement. GSK is ...

It was one of those conversations you never forget. We were discussing – of all things – the Covid injections, and I was questioning the early ‘safe and effective’ claims put forward by the pharmaceut ...

Mehta said HUL's focus would continue to ensure uninterrupted supplies of COVID relevant portfolio and meeting the demand arising out of evolving consumer needs ...